Hôpital Taher Sfar
Mahdia, Tunisia
NCT Number: NCT07825922
Tonsillectomy is one of the most frequently performed surgical procedures in children and is commonly associated with significant postoperative pain. Peritonsillar infiltration with local anesthetics such as Ropivacaine has been proposed to improve analgesia, but evidence remains inconsistent. This study aimed to evaluate the analgesic efficacy of peritonsillar Ropivacaine infiltration in pediatric tonsillectomy.
Looking for future studies?
Notify Me3 year–6 year
All sexes
Interventional
Not applicable
Mahdia, Tunisia
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Under general anesthesia and before surgical incision, the patient was positioned in Rose's position. Infiltration with ropivacaine was performed after intubation and before incision at three points (superior, middle, and inferior poles, including the posterior pillar), using a 23 gauge needle inserted between the pharyngeal muscles and tonsillar capsule.
Under general anesthesia and before surgical incision, the patient was positioned in Rose's position. Infiltration with normal saline was performed after intubation and before incision at three points (superior, middle, and inferior poles, including the posterior pillar), using a 23 gauge needle inserted between the pharyngeal muscles and tonsillar capsule.
Normal saline 0.9%, 5 mL, administered (2.5 mL per tonsillar bed)
Ropivacaine 0.2%, 5 mL, administered (2.5 mL per tonsillar bed)
Time frame: From the end of surgery until 24 hours postoperatively
Time from the end of surgery to the first administration of rescue analgesic medication. The time was recorded in hours.
Time frame: Perioperative.
It refers to the total dose of remifentanil administered to the patient during the entire surgical procedure. It reflects the amount of opioid used for intraoperative analgesia.
Time frame: In the first 24 hours postoperatively
It refers to the total dose of paracetamol consumed in the first 24 hours postoperatively, normalized per kilogram of body weight (mg/kg).
Time frame: From the end of surgery until first oral intake, assessed during the first 24 hours after surgery.
Time from the end of surgery to the first oral intake, expressed in hours.
Time frame: At 0, 2, 4, 8, 12 and 24 hours after surgery
Postoperative pain intensity assessed using the Face, Legs, Activity, Cry, Consolability scale (FLACC), ranging from 0 (no pain) to 10 (worst possible pain).
Time frame: At 24 hours after surgery
Parents' satisfaction was assessed using a 5-point Likert scale, where 1 indicated very dissatisfied, 5 very satisfied.
Time frame: Perioperative.
Occurrence of adverse effects (hypotension, bradycardia, arrhythmia, or local anesthetic toxicity) during or after surgery.
Time frame: Perioperative.
Once the FLACC score will be ≥ 4, rescue analgesia in the form of tramadol will be given.
Time frame: Perioperative.
It refers to the surgical dissection evaluated by the surgeon, easy, moderately easy or hard.
Time frame: Perioperative.
It refers to the the systolic blood pressure collected intraoperatively every ten minutes.
Time frame: Perioperative.
It refers to the diastolic blood pressure collected intraoperatively every ten minutes.
Time frame: Perioperative.
It refers to the heart rate collected intraoperatively every ten minutes.
University Hospital, Mahdia
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05504967
Agnosia, Nervous System Diseases
Braga, Portugal
View Trial DetailsNCT00730340
Children, Tonsillectomy
Oklahoma City, Oklahoma, United States
View Trial DetailsNCT07821931
Acute Pain, Agnosia
Palo Alto, California, United States
View Trial DetailsNCT07760207
Agnosia, Nervous System Diseases
View Trial Details